For our Spotlight on biomarker discovery and development we carried out a survey to gain insights into biomarkers used, their challenges and future outlook.
Browsing: neurodegenerative disease
In this report from Future Neurology, researchers describe the application and state of development of a range of CSF biomarkers in common neurodegenerative disorders.
Researchers have identified a simple blood test that may be able to diagnose neurodegeneration before symptoms arise; this could lead to earlier diagnosis of Alzheimer’s disease.
A new imaging study will be the first to use the GE180 ligand tracer to detect neuroinflammation in Parkinson’s and Alzheimer’s disease brains.
New studies reveal that exosomes transported between cells produce a wide-range of effects neurologically and throughout the body, from passing the effects of trauma onto the next generation to helping neurons communicate.
Researchers from Tufts University have developed 3D human tissue culture models for the CNS. This may facilitate the discovery of new treatment methods for neurodegenerative diseases.
Digital brain simulates patterns of atrophy associated with neurodegenerative diseases through altering the initial starting zone of toxic proteins.
In this interview, we spoke with Giovanni Frisoni about his talk on gut microbiome alterations and what impact this research could have for patients.
Exploring the use of antisense therapy for neurodegenerative diseases: an interview with Frank Bennett
In this interview, Frank Bennett speaks to us about the work on IONIS-HTTRx in patients with early-stage Huntington’s disease and how this therapy could be applied to treat other neurodegenerative diseases.
This week, our industry report covers neuroblastoma, DUB inhibitors for neurodegenerative diseases and pediatric multiple sclerosis.